Filter

331-340 of 380 results

  • KFF COVID-19 Vaccine Monitor: In Their Own Words

    Poll Finding

    This report summarizes the public’s response to a series of open-ended questions aimed at better understanding people’s concerns around receiving a COVID-19 vaccine and the views of the messages and messengers that could affect their willingness to get one,

  • New Analysis: Updated State Data Continues To Show Wide Disparities in COVID-19 Vaccination Rates by Race/Ethnicity

    News Release

    KFF has an updated analysis of state-reported data as of February 16, 2021 on COVID-19 vaccinations, cases, and deaths by race/ethnicity. New to the analysis are comparisons of vaccination rates in each racial/ethnic group based on state-reported data of total people who have received at least one dose of the vaccine. Among just over half of states reporting data, the vaccination rate among White people is over three times higher than the rate for Hispanic…

  • Tracking Global COVID-19 Vaccine Equity

    Issue Brief

    This analysis looks at global COVID-19 vaccination efforts by income-level and region to assess the equity gap in both vaccination coverage and rates of administration. Overall, we find that low-income countries and countries are lagging behind, and based on current rates, are unlikely to meet global vaccination targets.

  • COVID-19 Vaccine Breakthrough Cases: Data from the States

    Policy Watch

    We reviewed the websites and other official state sources for all 50 states and D.C. to see which are providing data on COVID-19 breakthrough cases, hospitalizations and deaths, how regularly, and what those data may tell us.

  • COVID-19 Vaccine Breakthrough Cases Are Extremely Rare, According to KFF State Data Analysis

    News Release

    As COVID-19 cases increase along with spread of the more transmissible Delta variant, the effectiveness of COVID-19 vaccines continues to be an important topic. A new KFF analysis looks at COVID-19 vaccine “breakthrough cases,” when fully vaccinated individuals become infected, as well as hospitalizations and deaths, to see which states are providing data on breakthrough events, how regularly, and what those data reveal. After a review of the websites of all states and D.C. and…

  • How Full FDA Approval Could Spur Vaccination

    From Drew Altman

    In this Axios column, Drew Altman says full FDA approval of COVID-19 vaccines can provide a big boost to vaccination efforts if treated as an opportunity for updated messaging from government officials at all levels and public health experts and new actions from employers.